Literature DB >> 7691928

LKM1 appearance in a HLA-DR3+ patient with chronic hepatitis C during interferon treatment.

L Muratori, D Zauli, F Giostra, G Ballardini, M Lenzi, F Cassani, F B Bianchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7691928     DOI： 10.1016/s0168-8278(05)80258-2

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  5 in total

Review 1.  Autoimmune hepatitis and its variant syndromes.

Authors:  Z Ben-Ari; A J Czaja
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

2.  Development of transient autoimmune hepatitis during interferon treatment of chronic hepatitis B.

Authors:  J Cianciara; T Laskus
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

3.  Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane.

Authors:  L Muratori; M Parola; A Ripalti; G Robino; P Muratori; G Bellomo; R Carini; M Lenzi; M P Landini; E Albano; F B Bianchi
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

4.  Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection.

Authors:  G V Gregorio; P Pensati; R Iorio; A Vegnente; G Mieli-Vergani; D Vergani
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

5.  Low prevalence of liver-kidney microsomal autoantibodies of type 1 (LKM1) in hepatitis C seropositive subjects on Crete, Greece.

Authors:  D Drygiannakis; C Lionis; I Drygiannakis; G Pappas; E Kouroumalis
Journal:  BMC Gastroenterol       Date:  2001-06-11       Impact factor: 3.067
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.